Owens & Minor (NYSE:OMI) Issues FY 2024 Earnings Guidance

Owens & Minor (NYSE:OMI) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided EPS guidance of 1.450-1.550 for the period, compared to the consensus EPS estimate of 1.590. The company issued revenue guidance of $10.6 billion-$10.8 billion, compared to the consensus revenue estimate of $10.7 billion. Owens & Minor also updated its FY24 guidance to $1.45-1.55 EPS.

Owens & Minor Price Performance

Shares of Owens & Minor stock opened at $13.61 on Thursday. Owens & Minor has a 52 week low of $11.42 and a 52 week high of $28.35. The company has a current ratio of 1.09, a quick ratio of 0.51 and a debt-to-equity ratio of 2.11. The stock has a market cap of $1.05 billion, a PE ratio of -20.94, a price-to-earnings-growth ratio of 0.39 and a beta of 0.41. The company’s 50-day moving average price is $14.41 and its two-hundred day moving average price is $16.08.

Owens & Minor (NYSE:OMI) last released its earnings results on Monday, November 4th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The business had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.44 EPS. As a group, sell-side analysts anticipate that Owens & Minor will post 1.55 EPS for the current fiscal year.

Analyst Ratings Changes

OMI has been the topic of a number of recent research reports. Barclays decreased their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a report on Tuesday. Robert W. Baird cut their price objective on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a report on Tuesday. StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Monday, August 26th. UBS Group cut their price target on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday. Finally, Citigroup lowered their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Owens & Minor has an average rating of “Hold” and an average price target of $18.50.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.